Mendez-Alvarez E - Search Results

1

Fine molecular tuning at position 4 of 2H-chromen-2-one derivatives in the search of potent and selective monoamine oxidase B inhibitors.

Pisani L, Catto M, Nicolotti O, Grossi G, Di Braccio M, Soto-Otero R, Mendez-Alvarez E, Stefanachi A, Gadaleta D, Carotti A. Pisani L, et al. Eur J Med Chem. 2013;70:723-39. doi: 10.1016/j.ejmech.2013.09.034. Epub 2013 Oct 17. Eur J Med Chem. 2013. PMID: 24231308

2

Inhibition of brain monoamine oxidase by adducts of 1,2,3,4-tetrahydroisoquinoline with components of cigarette smoke.

Méndez-Alvarez E, Soto-Otero R, Sánchez-Sellero I, López-Rivadulla Lamas M. Méndez-Alvarez E, et al. Life Sci. 1997;60(19):1719-27. doi: 10.1016/s0024-3205(97)00114-8. Life Sci. 1997. PMID: 9129127

3

Inhibition of brain monoamine oxidase activity by the generation of hydroxyl radicals: potential implications in relation to oxidative stress.

Soto-Otero R, Méndez-Alvarez E, Hermida-Ameijeiras A, Sánchez-Sellero I, Cruz-Landeira A, Lamas ML. Soto-Otero R, et al. Life Sci. 2001 Jul 13;69(8):879-89. doi: 10.1016/s0024-3205(01)01178-x. Life Sci. 2001. PMID: 11488401

4

Autoxidation and MAO-mediated metabolism of dopamine as a potential cause of oxidative stress: role of ferrous and ferric ions.

Hermida-Ameijeiras A, Méndez-Alvarez E, Sánchez-Iglesias S, Sanmartín-Suárez C, Soto-Otero R. Hermida-Ameijeiras A, et al. Neurochem Int. 2004 Jul;45(1):103-16. doi: 10.1016/j.neuint.2003.11.018. Neurochem Int. 2004. PMID: 15082228

5

A QSAR model for in silico screening of MAO-A inhibitors. Prediction, synthesis, and biological assay of novel coumarins.

Santana L, Uriarte E, González-Díaz H, Zagotto G, Soto-Otero R, Méndez-Alvarez E. Santana L, et al. J Med Chem. 2006 Feb 9;49(3):1149-56. doi: 10.1021/jm0509849. J Med Chem. 2006. PMID: 16451079

6

Reduction of dopaminergic degeneration and oxidative stress by inhibition of angiotensin converting enzyme in a MPTP model of parkinsonism.

Muñoz A, Rey P, Guerra MJ, Mendez-Alvarez E, Soto-Otero R, Labandeira-Garcia JL. Muñoz A, et al. Neuropharmacology. 2006 Jul;51(1):112-20. doi: 10.1016/j.neuropharm.2006.03.004. Epub 2006 May 5. Neuropharmacology. 2006. PMID: 16678218

7

Ester derivatives of annulated tetrahydroazocines: a new class of selective acetylcholinesterase inhibitors.

Carotti A, de Candia M, Catto M, Borisova TN, Varlamov AV, Méndez-Alvarez E, Soto-Otero R, Voskressensky LG, Altomare C. Carotti A, et al. Bioorg Med Chem. 2006 Nov 1;14(21):7205-12. doi: 10.1016/j.bmc.2006.06.055. Epub 2006 Jul 14. Bioorg Med Chem. 2006. PMID: 16843666

8

Structural insights into monoamine oxidase inhibitory potency and selectivity of 7-substituted coumarins from ligand- and target-based approaches.

Catto M, Nicolotti O, Leonetti F, Carotti A, Favia AD, Soto-Otero R, Méndez-Alvarez E, Carotti A. Catto M, et al. J Med Chem. 2006 Aug 10;49(16):4912-25. doi: 10.1021/jm060183l. J Med Chem. 2006. PMID: 16884303

9

Synthesis and monoamine oxidase inhibitory activity of new pyridazine-, pyrimidine- and 1,2,4-triazine-containing tricyclic derivatives.

Carotti A, Catto M, Leonetti F, Campagna F, Soto-Otero R, Méndez-Alvarez E, Thull U, Testa B, Altomare C. Carotti A, et al. J Med Chem. 2007 Nov 1;50(22):5364-71. doi: 10.1021/jm070728r. Epub 2007 Oct 2. J Med Chem. 2007. PMID: 17910428

10

Inhibition of 6-hydroxydopamine-induced oxidative damage by 4,5-dihydro-3H-2-benzazepine N-oxides.

Soto-Otero R, Méndez-Alvarez E, Sánchez-Iglesias S, Zubkov FI, Voskressensky LG, Varlamov AV, de Candia M, Altomare C. Soto-Otero R, et al. Biochem Pharmacol. 2008 Apr 1;75(7):1526-37. doi: 10.1016/j.bcp.2007.12.010. Epub 2008 Jan 5. Biochem Pharmacol. 2008. PMID: 18275937

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters